Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

BIO a whirlwind for Cytovance

Get in Touch

By Jim Stafford

Copyright © 2014, The Oklahoma Publishing Company

SAN DIEGO — The 2014 Biotechnology Industry Organization convention is a whirlwind of potential success for Darren Head, president and CEO of Oklahoma City-based Cytovance Biologics Inc. Prospective customers are filling up his calendar and keeping the Cytovance exhibition space buzzing.

“We’ve had more leads in our first day than in all the previous BIO shows combined,” Head said Wednesday morning just after completing the first business meeting of the day at a conference area located in the Cytovance booth space.

cytovance meetinng“It’s been crazy for us,” Head said. “I don’t know if it’s just the timing or the way the company’s growing or what’s going on. But it’s a lot of activity.”

Founded in 2003 by former executives of Novazyme Pharmaceuticals, Cytovance delivers a broad menu of specialized contract biological manufacturing services that help companies such as Oklahoma City’s Selexys Pharmaceuticals manufacture drugs for clinical trials.

The company has grown at a phenomenal pace since Head became its chief executive just over six years ago. It has grown from 30 employees to 135, many of them highly paid scientists.

Revenue is almost 20 times the $1.5 million generated in 2008. New, larger bioreactors have been installed in the company’s 44,000 square foot manufacturing facility at the University Research Park. Manufacturing capabilities have expanded, as well.

“We’re profitable, moving quickly to commercialization,” Head said. “We hope to have our first commercial product coming down the pipeline. We developed it for another company. It’s pretty exciting.”

Cytovance maintains its own exhibition space apart from the OKBio booth at the BIO show, largely because it wants to have a presence among its competitors in the contract manufacturing industry at the show.

“We still support the OKBio group, working behind the scenes,” Head said. “But what I’m seeing is that our booth is growing at such a fast pace that handling our own is a challenge. So, we’re less hands-on with OKBio, but still supporting it.”

On Wednesday, a half a dozen Cytovance employees staffed the exhibition space, which is twice as large as past BIO shows.

“I would say we’ve probably had over 40 meetings already,” Head said.

Booksigning

Another busy Oklahoma entrepreneur at the BIO meeting has been Craig Shimasaki, a serial entrepreneur and CEO of Moleculera Labs. The company provides neurological testing of children who suffer from tics, obsessive compulsive symptoms and out-of-control behaviors.

On Wednesday, Shimasaki held his second booksigning of the show at the BIO bookstore just off the main exhibition floor at the San Diego Convention Center. Buyers lined up to obtain the author’s signature for Shimasaki’s most recent book, “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies.”

The book was written in cooperation with a number of other notable biotech industry leaders, including BIO president and CEO Jim Greenwood.

Shimasaki participated in the BIO Entrepreneurship Bootcamp last weekend before the opening of the show, which generated a high level of interest in the new book.

“The book is being used a lot of different areas for people who are working in the biotech industry, people who are supporting the biotech industry and in the teaching programs for future entrepreneurs,” he said.

Click here to read the article at newsok.com

 

 

  • admin
    admin

More News

Loading...
Black doctor smiling with stethoscope
Blog, i2E
02.09.23

Titan Intake Automates Patient Referrals to Accelerate Care

Read more
man and woman reviewing paperwork at a table
Blog, i2E, News
01.10.23

Stories of Oklahoma Innovation: Building a Startup

Read more
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E